BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16882313)

  • 1. A kinase-focused compound collection: compilation and screening strategy.
    Sun D; Chuaqui C; Deng Z; Bowes S; Chin D; Singh J; Cullen P; Hankins G; Lee WC; Donnelly J; Friedman J; Josiah S
    Chem Biol Drug Des; 2006 Jun; 67(6):385-94. PubMed ID: 16882313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER; Blake JF
    Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.
    Kumar A; Siddiqi MI
    J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput virtual screening of proteins using GRID molecular interaction fields.
    Sciabola S; Stanton RV; Mills JE; Flocco MM; Baroni M; Cruciani G; Perruccio F; Mason JS
    J Chem Inf Model; 2010 Jan; 50(1):155-69. PubMed ID: 19919042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J; Rarey M
    J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening to successfully identify novel janus kinase 3 inhibitors: a sequential focused screening approach.
    Chen X; Wilson LJ; Malaviya R; Argentieri RL; Yang SM
    J Med Chem; 2008 Nov; 51(21):7015-9. PubMed ID: 18844338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
    Fukunishi Y; Hojo S; Nakamura H
    J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for designing GPCR-focused libraries and screening sets.
    Jimonet P; Jäger R
    Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps.
    Schneider G; Nettekoven M
    J Comb Chem; 2003; 5(3):233-7. PubMed ID: 12739938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.
    Gozalbes R; Simon L; Froloff N; Sartori E; Monteils C; Baudelle R
    J Med Chem; 2008 Jun; 51(11):3124-32. PubMed ID: 18479119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
    Renner S; Schneider G
    J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge-based design of target-focused libraries using protein-ligand interaction constraints.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2006 Jan; 49(2):490-500. PubMed ID: 16420036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based virtual screening of Src kinase inhibitors.
    Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
    Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
    Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
    Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.